Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HER2-low breast cancers: Current insights and future directions.
Zhang H, Karakas C, Tyburski H, Turner BM, Peng Y, Wang X, Katerji H, Schiffhauer L, Hicks DG. Zhang H, et al. Among authors: karakas c. Semin Diagn Pathol. 2022 Sep;39(5):305-312. doi: 10.1053/j.semdp.2022.07.003. Epub 2022 Jul 9. Semin Diagn Pathol. 2022. PMID: 35872032 Review.
Corrigendum to "Immunohistochemistry in the workup of bladder biopsies. Frequency, variation and utility of use at an academic center" [Ann. Diagn. Pathol. 41(2019) 124-128].
McIntire P, Khan R, Kilic I, Adams D, Karakaş C, Wojcik EM, Pambuccian SE, Barkan GA. McIntire P, et al. Among authors: karakas c. Ann Diagn Pathol. 2020 Jun;46:151513. doi: 10.1016/j.anndiagpath.2020.151513. Epub 2020 Apr 21. Ann Diagn Pathol. 2020. PMID: 32330661 No abstract available.
A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer.
Mitri Z, Karakas C, Wei C, Briones B, Simmons H, Ibrahim N, Alvarez R, Murray JL, Keyomarsi K, Moulder S. Mitri Z, et al. Among authors: karakas c. Invest New Drugs. 2015 Aug;33(4):890-4. doi: 10.1007/s10637-015-0244-4. Epub 2015 May 7. Invest New Drugs. 2015. PMID: 25947565 Clinical Trial.
Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer.
Hunt KK, Karakas C, Ha MJ, Biernacka A, Yi M, Sahin AA, Adjapong O, Hortobagyi GN, Bondy M, Thompson P, Cheung KL, Ellis IO, Bacus S, Symmans WF, Do KA, Keyomarsi K. Hunt KK, et al. Among authors: karakas c. Clin Cancer Res. 2017 Jun 15;23(12):2991-3002. doi: 10.1158/1078-0432.CCR-16-2217. Epub 2016 Nov 23. Clin Cancer Res. 2017. PMID: 27881578 Free PMC article.
Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration.
Chen X, Yang D, Carey JPW, Karakas C, Albarracin C, Sahin AA, Arun BK, Guray Durak M, Li M, Kohansal M, Bui TN, Ha MJ, Hunt KK, Keyomarsi K. Chen X, et al. Among authors: karakas c. Cancers (Basel). 2021 Apr 1;13(7):1656. doi: 10.3390/cancers13071656. Cancers (Basel). 2021. PMID: 33916118 Free PMC article.
Paget's disease of the breast.
Karakas C. Karakas C. J Carcinog. 2011;10:31. doi: 10.4103/1477-3163.90676. Epub 2011 Dec 8. J Carcinog. 2011. PMID: 22279416 Free PMC article.
71 results